82 related articles for article (PubMed ID: 17503469)
1. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells.
Weng C; Cai J; Wen J; Yuan H; Yang K; Imperato-McGinley J; Zhu YS
Int J Oncol; 2013 Jan; 42(1):327-37. PubMed ID: 23135751
[TBL] [Abstract][Full Text] [Related]
3. Receptor isoform and ligand-specific modulation of dihydrotestosterone-induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens.
Zhu YS; Cai LQ; Huang Y; Fish J; Wang L; Zhang ZK; Imperato-McGinley JL
J Androl; 2005; 26(4):500-8; discussion 509-10. PubMed ID: 15955889
[TBL] [Abstract][Full Text] [Related]
4. 17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.
Qiao Y; Zhang ZK; Cai LQ; Tan C; Imperato-McGinley JL; Zhu YS
Prostate; 2007 Dec; 67(16):1719-28. PubMed ID: 17879940
[TBL] [Abstract][Full Text] [Related]
5. The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells.
Vollmer G; Helle J; Amri H; Liu X; Arnold JT
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):153-62. PubMed ID: 22207083
[TBL] [Abstract][Full Text] [Related]
6. Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells?
Bennett HL; Stockley J; Fleming JT; Mandal R; O'Prey J; Ryan KM; Robson CN; Leung HY
BJU Int; 2013 Apr; 111(4):672-82. PubMed ID: 22897391
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer.
Qiao Y; Wang L; Cai LQ; Tan C; Imperato-McGinley J; Zhu YS
J Urol; 2011 Jan; 185(1):305-14. PubMed ID: 21075385
[TBL] [Abstract][Full Text] [Related]
8. Adrenal androgens rescue prostatic dihydrotestosterone production and growth of prostate cancer cells after castration.
Wu Y; Tang L; Azabdaftari G; Pop E; Smith GJ
Mol Cell Endocrinol; 2019 Apr; 486():79-88. PubMed ID: 30807787
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells.
Zhang Y; Ni J; Messing EM; Chang E; Yang CR; Yeh S
Proc Natl Acad Sci U S A; 2002 May; 99(11):7408-13. PubMed ID: 12032296
[TBL] [Abstract][Full Text] [Related]
10. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation.
Migliaccio A; Castoria G; Di Domenico M; de Falco A; Bilancio A; Lombardi M; Barone MV; Ametrano D; Zannini MS; Abbondanza C; Auricchio F
EMBO J; 2000 Oct; 19(20):5406-17. PubMed ID: 11032808
[TBL] [Abstract][Full Text] [Related]
11. Does changing androgen receptor status during prostate cancer development impact upon cholesterol homeostasis?
Krycer JR; Brown AJ
PLoS One; 2013; 8(1):e54007. PubMed ID: 23320115
[TBL] [Abstract][Full Text] [Related]
12. Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer.
Bossan A; Ottman R; Andl T; Hasan MF; Mahajan N; Coppola D; Chakrabarti R
BMC Cancer; 2018 Dec; 18(1):1257. PubMed ID: 30558664
[TBL] [Abstract][Full Text] [Related]
13. AR inhibitors identified by high-throughput microscopy detection of conformational change and subcellular localization.
Jones JO; An WF; Diamond MI
ACS Chem Biol; 2009 Mar; 4(3):199-208. PubMed ID: 19236099
[TBL] [Abstract][Full Text] [Related]
14. 3βHSD activity saturates at physiological substrate concentrations in intact cells.
McManus JM; Chung YM; Sharifi N
Prostate; 2023 Sep; 83(13):1306-1309. PubMed ID: 37321973
[TBL] [Abstract][Full Text] [Related]
15. Structure based docking and biological evaluation towards exploring potential anti-cancerous and apoptotic activity of 6-Gingerol against human prostate carcinoma cells.
Khan H; Azad I; Arif Z; Parveen S; Kumar S; Rais J; Ansari JA; Nasibullah M; Kumar S; Arshad M
BMC Complement Med Ther; 2024 Jan; 24(1):8. PubMed ID: 38166796
[TBL] [Abstract][Full Text] [Related]
16. Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancer.
Yang JS; Qian C; You S; Rotinen M; Posadas EM; Freedland SJ; Di Vizio D; Kim J; Freeman MR
Am J Clin Exp Urol; 2021; 9(4):337-349. PubMed ID: 34541032
[TBL] [Abstract][Full Text] [Related]
17. Selective Androgen Receptor Modulators-Transformative Drugs or Heralds of the Next Drug Epidemic?
Hahamyan HA; Basaria S
JAMA; 2024 Apr; 331(16):1359-1360. PubMed ID: 38526456
[TBL] [Abstract][Full Text] [Related]
18. Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer.
Zhang X; Wang Z; Huang S; He D; Yan W; Zhuang Q; Wang Z; Wang C; Tan Q; Liu Z; Yang T; Liu Y; Ren R; Li J; Butler W; Tang H; Wei GH; Li X; Wu D; Li Z
J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 38099500
[TBL] [Abstract][Full Text] [Related]
19. Reduction in Nuclear Size by DHRS7 in Prostate Cancer Cells and by Estradiol Propionate in DHRS7-Depleted Cells.
Rizzotto A; Tollis S; Pham NT; Zheng Y; Abad MA; Wildenhain J; Jeyaprakash AA; Auer M; Tyers M; Schirmer EC
Cells; 2023 Dec; 13(1):. PubMed ID: 38201261
[TBL] [Abstract][Full Text] [Related]
20. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Gillessen S; Omlin A; Attard G; de Bono JS; Efstathiou E; Fizazi K; Halabi S; Nelson PS; Sartor O; Smith MR; Soule HR; Akaza H; Beer TM; Beltran H; Chinnaiyan AM; Daugaard G; Davis ID; De Santis M; Drake CG; Eeles RA; Fanti S; Gleave ME; Heidenreich A; Hussain M; James ND; Lecouvet FE; Logothetis CJ; Mastris K; Nilsson S; Oh WK; Olmos D; Padhani AR; Parker C; Rubin MA; Schalken JA; Scher HI; Sella A; Shore ND; Small EJ; Sternberg CN; Suzuki H; Sweeney CJ; Tannock IF; Tombal B
Ann Oncol; 2015 Aug; 26(8):1589-604. PubMed ID: 26041764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
